How Inhaled mRNA May Help Rare Disease Patients Breathe Easier

Thomas Langenickel, chief medical officer of Ethris, discusses how the company’s technology overcomes existing challenges for the therapeutic use of mRNA, its ability to deliver treatments directly to the lung through inhalation, and its pipeline of therapies in development.